United Capital Financial Advisers, LLC Axogen, Inc. Transaction History
United Capital Financial Advisers, LLC
- $19.9 Billion
- Q3 2024
A detailed history of United Capital Financial Advisers, LLC transactions in Axogen, Inc. stock. As of the latest transaction made, United Capital Financial Advisers, LLC holds 21,225 shares of AXGN stock, worth $312,856. This represents 0.0% of its overall portfolio holdings.
Number of Shares
21,225
Previous 21,251
0.12%
Holding current value
$312,856
Previous $153,000
94.12%
% of portfolio
0.0%
Previous 0.0%
Shares
5 transactions
Others Institutions Holding AXGN
# of Institutions
163Shares Held
36.6MCall Options Held
230KPut Options Held
400-
First Light Asset Management, LLC Edina, MN4.09MShares$60.3 Million5.0% of portfolio
-
Black Rock Inc. New York, NY3.25MShares$47.9 Million0.0% of portfolio
-
Soleus Capital Management, L.P. Greenwich, CT3.01MShares$44.3 Million3.58% of portfolio
-
Morgan Stanley New York, NY2.9MShares$42.8 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.43MShares$35.8 Million0.0% of portfolio
About Axogen, Inc.
- Ticker AXGN
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 42,283,700
- Market Cap $623M
- Description
- AxoGen, Inc., together with its subsidiaries, develops and markets surgical solutions for physical damage or transection to peripheral nerves. The company's products include Avance Nerve Graft, a biologically active off-the-shelf processed human nerve allograft for bridging severed nerves without the comorbidities associated with a second surgic...